LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $69,000 | -21.6% | 252 | 0.0% | 0.00% | – |
Q2 2022 | $88,000 | -48.5% | 252 | 0.0% | 0.00% | – |
Q1 2022 | $171,000 | -83.1% | 252 | -42.3% | 0.00% | – |
Q4 2021 | $1,009,000 | -54.8% | 437 | -10.3% | 0.00% | – |
Q3 2021 | $2,230,000 | +3.1% | 487 | 0.0% | 0.00% | – |
Q2 2021 | $2,162,000 | -85.9% | 487 | -76.8% | 0.00% | – |
Q1 2021 | $15,310,000 | -34.9% | 2,103 | -31.8% | 0.00% | – |
Q4 2020 | $23,516,000 | -20.0% | 3,082 | -4.8% | 0.00% | – |
Q3 2020 | $29,410,000 | +161.8% | 3,239 | +143.9% | 0.00% | – |
Q2 2020 | $11,235,000 | -18.7% | 1,328 | -52.5% | 0.00% | – |
Q1 2020 | $13,817,000 | +62.2% | 2,797 | +136.4% | 0.00% | – |
Q4 2019 | $8,518,000 | -40.9% | 1,183 | -11.3% | 0.00% | – |
Q3 2019 | $14,421,000 | +15.2% | 1,334 | +38.5% | 0.00% | – |
Q2 2019 | $12,519,000 | – | 963 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |